Utama › Kanser Darah › Nebraska › Omaha
Kajian klinikal Kanser Darah di Omaha, NE
10 kajian untuk Kanser Darah sedang mencari peserta di lokasi dalam dan sekitar Omaha (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Mengambil pesertaKajian pemerhatian
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Mengambil pesertaFasa 1
- The University of Nebraska Medical Center, Omaha
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- University of Nebraska Medical Center, Omaha
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- University of Nebraska Medical Center, Omaha
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- University of Nebraska Medical Center, Omaha
Halt Aging in Survivors of Blood Cancers
Mengambil peserta
- University of Nebraska Medical Center, Omaha
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Mengambil pesertaFasa 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Mengambil pesertaFasa 1/2
- Fred and Pamela Buffett Cancer Center, Omaha
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Mengambil pesertaFasa 2
- University of Nebraska Medical Center, Omaha
Kajian Kanser Darah di bandar lain
- Houston, TX46 kajian
- New York City, NY26 kajian
- Boston, MA25 kajian
- Washington, DC19 kajian
- Seattle, WA18 kajian
- Baltimore, MD18 kajian
- Los Angeles, CA17 kajian
- Durham, NC16 kajian
- Chicago, IL15 kajian
- Philadelphia, PA14 kajian
- Columbus, OH13 kajian
- Edison, NJ13 kajian
Kajian lain di Omaha
- Kanser Prostat27 kajian
- Kanser Paru-paru Bukan Sel Kecil24 kajian
- Kanser Payudara22 kajian
- Kanser (semua jenis)18 kajian
- Kanser Kolorektal18 kajian
- Mieloma Pelbagai16 kajian
- Kanser Ovari14 kajian
- Limfoma Bukan Hodgkin14 kajian
- Kanser Pankreas14 kajian
- Kanser Metastatik13 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher13 kajian
- Kegagalan Jantung13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.